Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NeuroDerm Ltd NDRM

Healthcare Biotechnology
"NeuroDerm Ltd is a clinical-stage pharmaceutical company developing next-generation treatments for central nervous system diseases, including Parkinson's disease as well as other CNS diseases."

Recent & Breaking News (NDAQ:NDRM)

Mitsubishi Tanabe Pharma Corporation Completes Acquisition of NeuroDerm

GlobeNewswire October 18, 2017

NeuroDerm Shareholders Approve Proposed Acquisition by Mitsubishi Tanabe Pharma Corporation

GlobeNewswire September 12, 2017

Viceroy Research Believes Mitsubishi Tanabe’s $1.1B Acquisition of Neuroderm Will Result in Complete Writeoff

Business Wire August 30, 2017

Stocks Under Scanner in the Biotech Space -- Merrimack Pharma, MannKind, NeuroDerm, and Celsion

PR Newswire August 23, 2017

NeuroDerm Announces Second Quarter 2017 Financial Results

GlobeNewswire August 3, 2017

NeuroDerm Announces Extraordinary General Meeting of Shareholders to Approve Acquisition by Mitsubishi Tanabe Pharma Corporation

GlobeNewswire August 1, 2017

Mid-Afternoon Market Update: WebMD Health Climbs On Acquisition News; Hasbro Shares Slide

Benzinga.com  July 24, 2017

NeuroDerm Enters Definitive Agreement to be Acquired by Mitsubishi Tanabe Pharma Corporation for US$1.1 Billion in Cash

GlobeNewswire July 24, 2017

Results of NeuroDerm’s ND0612H Phase II Trial Presented in Oral Session at the 3rd Congress of the European Academy of Neurology

GlobeNewswire June 27, 2017

Wall Street's M&A Chatter From June 12: Neuroderm, Penn Virginia, Tesaro, Synaptics-Conexant

Benzinga.com  June 13, 2017

NeuroDerm Presents Six Posters at the 21st International Congress of Parkinson’s Disease and Movement Disorders

GlobeNewswire June 8, 2017

European Medicines Agency Accepts Design of NeuroDerm’s ND0612 Phase III iNDiGO Efficacy Trial

GlobeNewswire June 6, 2017

NeuroDerm Presents ND0612H Phase II Trial Results in Late-Breaking Poster Session at the 21st International Congress of Parkinson’s Disease and Movement Disorders

GlobeNewswire June 5, 2017

NeuroDerm CEO to Present at the Jefferies Global Healthcare Conference on June 7, 2017

GlobeNewswire May 30, 2017

NeuroDerm ND0612H Phase II Trial Results to be Presented in Late-Breaking Session at the 21st International Congress of Parkinson’s Disease and Movement Disorders

GlobeNewswire May 23, 2017

NeuroDerm Announces First Quarter 2017 Financial Results

GlobeNewswire May 11, 2017

NeuroDerm Ltd. (Nasdaq: NDRM) to Ring The Nasdaq Stock Market Opening Bell

GlobeNewswire April 20, 2017

NeuroDerm to Ring the Nasdaq Stock Market Opening Bell and Participate in the Parkinson’s Unity Walk

GlobeNewswire April 20, 2017

NeuroDerm to Host Investor Day on April 21, 2017

GlobeNewswire April 10, 2017

NeuroDerm Announces Fourth Quarter and Full Year 2016 Financial Results

GlobeNewswire March 30, 2017